Literature DB >> 14979582

Gender difference in the incidence of shingles.

D M Fleming1, K W Cross, W A Cobb, R S Chapman.   

Abstract

We investigated age- and gender-specific incidence of shingles reported in a large sentinel practice network monitoring a defined population over the years 1994-2001. In total, 5915 male and 8617 female incident cases were studied. For each age group, we calculated the relative risk of females to males presenting with shingles. Incidence rates of chickenpox and herpes simplex were examined similarly. Shingles incidence was greater in females in each age group (except for 15-24 years). Relative risks (female to male) were greatest in age groups 45-64 years (1.48) and 0-14 years (1.43). There were no gender differences in the incidence of chickenpox except in the 15-24 years age group (female excess): for herpes simplex there were female excesses in all age groups. Gender-specific age-standardized incidence rates of shingles were calculated for each year and showed a consistent female excess in each of the 8 years (average annual excess 28%).

Mesh:

Year:  2004        PMID: 14979582      PMCID: PMC2870070          DOI: 10.1017/s0950268803001523

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  41 in total

1.  Secular trends in the epidemiology of shingles in Alberta.

Authors:  M L Russell; D P Schopflocher; L Svenson; S N Virani
Journal:  Epidemiol Infect       Date:  2007-02-12       Impact factor: 2.451

2.  Clinical diagnosis of herpes zoster in family practice.

Authors:  Wim Opstelten; Anton M van Loon; Margje Schuller; Albert J M van Wijck; Gerrit A van Essen; Karel G M Moons; Theo J M Verheij
Journal:  Ann Fam Med       Date:  2007 Jul-Aug       Impact factor: 5.166

3.  Chronic pain patients' treatment preferences: a discrete-choice experiment.

Authors:  Axel C Mühlbacher; Uwe Junker; Christin Juhnke; Edgar Stemmler; Thomas Kohlmann; Friedhelm Leverkus; Matthias Nübling
Journal:  Eur J Health Econ       Date:  2014-06-21

Review 4.  Herpes zoster and the search for an effective vaccine.

Authors:  N Arnold; I Messaoudi
Journal:  Clin Exp Immunol       Date:  2016-07-25       Impact factor: 4.330

5.  Epidemiological Study on the Incidence of Herpes Zoster in Nearby Cheonan.

Authors:  Ho Soon Jung; Jin Ku Kang; Sie Hyeon Yoo
Journal:  Korean J Pain       Date:  2015-07-01

Review 6.  Immunosenescence: the Role of Aging in the Predisposition to Neuro-Infectious Complications Arising from the Treatment of Multiple Sclerosis.

Authors:  Elena Grebenciucova; Joseph R Berger
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08       Impact factor: 5.081

7.  Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster: a population-based study from primary care in Madrid (Spain).

Authors:  María D Esteban-Vasallo; M Felicitas Domínguez-Berjón; Ruth Gil-Prieto; Jenaro Astray-Mochales; Angel Gil de Miguel
Journal:  Hum Vaccin Immunother       Date:  2014-05-07       Impact factor: 3.452

8.  Epidemiology of herpes zoster infection among patients treated in primary care centres in the Valencian community (Spain).

Authors:  Ana M Cebrián-Cuenca; Javier Díez-Domingo; María San-Martín Rodríguez; Joan Puig-Barberá; Jorge Navarro-Pérez
Journal:  BMC Fam Pract       Date:  2010-05-06       Impact factor: 2.497

9.  Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study.

Authors:  Leonardo Emberti Gialloreti; Monica Merito; Patrizio Pezzotti; Luigi Naldi; Antonio Gatti; Maud Beillat; Laurence Serradell; Rafaelle di Marzo; Antonio Volpi
Journal:  BMC Infect Dis       Date:  2010-08-03       Impact factor: 3.090

10.  Examination of links between herpes zoster incidence and childhood varicella vaccination.

Authors:  Craig M Hales; Rafael Harpaz; M Riduan Joesoef; Stephanie R Bialek
Journal:  Ann Intern Med       Date:  2013-12-03       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.